Enlivex Therapeutics Ltd (NASDAQ:ENLV)
| 1.54 Delayed Data As of Sep 28 |  0.00 / 0.00%Today’s Change | 1.36 Today|||52-Week Range 4.92 | -60.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 17.0K | 25.0K | 12.0K | 121.0K | ||
| Operating Expenses | Gross Income | -17.0K | -25.0K | -12.0K | -121.0K | |
| General Expenses | 14.6M | 13.9M | 5.8M | 5.2M | ||
| Other Operating Expenses | 829.0K | 0.00 | 0.00 | 0.00 | ||
| Research And Development | 7.7M | 8.7M | 2.5M | 4.1M | ||
| Total Operating Expenses | 15.5M | 13.9M | 5.9M | 5.3M | ||
| Non-Operating Expenses | Operating Income | -15.5M | -13.9M | -5.9M | -5.3M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 132.0K | ||
| Extraordinary Charge | 0.00 | -1.9M | -105.0K | -- | ||
| Interest Expense On Debt | 12.0K | 0.00 | 0.00 | 3.0K | ||
| Other Expenses | -39.0K | -43.0K | -1.0K | 790.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -15.3M | -15.8M | -5.9M | -4.2M | |
| Income Taxes | -24.0K | -216.0K | -28.0K | 0.00 | ||
| Net Income | -15.4M | -16.0M | -5.9M | -4.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 355.8K | 397.7K | 414.2K | 438.7K | |
| Shares To Calculate EPS Diluted | 355.8K | 397.7K | 414.2K | 438.7K | ||
| Earnings Per Share | EPS | -$43.20 | -$40.40 | -$14.32 | -$11.20 | |
| EPS Diluted | -$43.20 | -$40.40 | -$14.32 | -$11.17 | ||
